Furthermore, we found that Tim-3+ CD4+ T cells from T2DM patients have a much weaker capacity to produce TNF-α and IFN-γ after PMA/ionomycin induction (Supplementary Figure S5A). The gene discussed is CD4; the disease is type 2 diabetes mellitus.